Asymptote

Cambridge, United Kingdom Founded: 1989 • Age: 37 yrs Acquired By GE Healthcare
Cryopreservation products for biological samples are developed without liquid nitrogen.

About Asymptote

Asymptote is a Healthcare company based in Cambridge (United Kingdom) founded in 1989, and was acquired by GE Healthcare in April 2017. Cryopreservation products for biological samples are developed without liquid nitrogen. Its chief executive, as recorded, is John Morris. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified. Its legal entity is ASYMPTOTE LIMITED.

Company details

Asymptote was founded in 1989 in Cambridge, United Kingdom, within the biotechnology sector. Controlled-rate freezing and thawing systems for live biological samples are provided, with emphasis on liquid nitrogen-free options compatible with clean-room environments. Cryogenic chain technology is employed across operations. The product lineup consists of VIA Freeze research, VIA Freeze duo, and VIA Freeze quad freezers, alongside the VIA thaw automated system, supporting research and storage needs.

  • Headquarters Cambridge, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website asymptote.co.uk
  • Social LinkedIn
  • Acquired by GE Healthcare (Apr 2017)
  • Legal Name Asymptote Limited
  • Date of Incorporation 22 Sep, 1989
  • Jurisdiction CAMBRIDGE, UNITED KINGDOM
Key Metrics

Funding Insights of Asymptote

  • Total Rounds 1
  • Last Round Grant β€” $54,021
  • First Round $54,021

    (Jan 2018)

  • Investors Count 1

All 1 funding rounds of Asymptote with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2018$54,021Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Asymptote

Asymptote has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include GE Healthcare and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Materials management solutions are provided for healthcare organizations.
1892gehealthcare.comChicago, United States
Premium access

Investor details for Asymptote

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Asymptote

1 people are tracked at Asymptote (1 in leadership).

NameRoleGroup
John Morris
CEOLeadership
Premium access

Complete people profiles for Asymptote

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Asymptote

3 dated milestones of Asymptote across 29 years, from founding to its latest funding, stage changes and deals.

  1. Founded Asymptote is founded.
  2. Exit Acquired by GE Healthcare.
  3. Funding First funding round of $54K.

Web traffic of Asymptote

Websites that share an audience with Asymptote (asymptote.co.uk).

Similar websites

Websites whose visitors overlap most with Asymptote. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nalgenunc.com
nalgenunc.com
100%
–
biogenics.com
100%
View details
cryologic.com
100%
#9,905,193View details
freezerpro.com
100%
View details
shivaniscientific.com
shivaniscientific.com
100%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Asymptote

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Asymptote (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Asymptote

Asymptote was founded in 1989 and raised its 1st funding round 29 years after it was founded.

Asymptote is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

John Morris is the CEO of Asymptote, as recorded in our data.

Asymptote was founded in 1989 in Cambridge, United Kingdom, within the biotechnology sector. Controlled-rate freezing and thawing systems for live biological samples are provided, with emphasis on liquid nitrogen-free options compatible with clean-room environments. Cryogenic chain technology is employed across operations. The product lineup consists of VIA Freeze research, VIA Freeze duo, and VIA Freeze quad freezers, alongside the VIA thaw automated system, supporting research and storage needs.

Asymptote has 2 investors. Key investors include GE Healthcare, and European Union.

Asymptote operates through Asymptote Limited.

Yes. Asymptote was acquired by GE Healthcare in April 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available